Innovating antibodies, improving lives

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

 

Q1 260x173First Quarter 2019 Financial Results

Genmab published its First Quarter 2019 financial results after market close on May 8 and held an investor conference call. Click here to listen to the replay of the webcast. Click here to download the results. Click here to view the conference call slides. Click here to download an MP3 of the webcast. 

 

Genmab 20 Years LogoCelebrating 20 Years

Genmab celebrates its 20th anniversary this year. We asked employees and external stakeholders for their perspectives on Genmab. Click here to watch the video and find out what they said.

 

 

join our team_260x173Career Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members. Click here to visit Genmab's page on LinkedIn.